Glycobiology, 2000, Vol. 10, No. 3 305-312
© 2000 Oxford University Press
Ultrastructural localization of sulfated and unsulfated keratan sulfate in normal and macular corneal dystrophy type I
Department of Biological Sciences, Institute of Environmental and Natural Sciences, Lancaster University, Lancaster LA1 4YQ, UK, 2Department of Optometry and Vision Sciences, Cardiff University, Cardiff, UK, and 3University of Manchester and Royal Manchester Eye Hospital, Manchester, UK
Keratan sulfate (KS) proteoglycans are of importance for the maintenance of corneal transparency as evidenced in the condition macular corneal dystrophy type I (MCD I), a disorder involving the absence of KS sulfation, in which the cornea becomes opaque. In this transmission electron microscope study quantitative immuno- and histochemical methods have been used to examine a normal and MCD I cornea. The monoclonal antibody, 5-D-4, has been used to localize sulfated KS and the lectin Erythrina cristagalli agglutinin (ECA) to localize poly N-acetyllactosamine (unsulfated KS). In normal cornea high levels of sulfated KS were detected in the stroma, Bowmans layer, and Descemets membrane and low levels in the keratocytes, epithelium and endothelium. Furthermore, in normal cornea, negligible levels of labeling were found for N-acetyllactosamine (unsulfated KS). In the MCD I cornea sulfated KS was not detected anywhere, but a specific distribution of N-acetyllactosamine (unsulfated KS) was evident: deposits found in the stroma, keratocytes, and endothelium labeled heavily as did the disrupted posterior region of Descemets membrane. However, the actual cytoplasm of cells and the undisrupted regions of stroma revealed low levels of labeling. In conclusion, little or no unsulfated KS is present in normal cornea, but in MCD I cornea the abnormal unsulfated KS was localized in deposits and did not associate with the collagen fibrils of the corneal stroma. This study has also shown that ECA is an effective probe for unsulfated KS.
1 To whom correspondence should be addressed
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
H. Xu, H. Kurihara, T. Ito, H. Kikuchi, K. Yoshida, H. Yamanokuchi, and A. Asari The Keratan Sulfate Disaccharide Gal(6S03) {beta}1,4-GlcNAc(6S03) Modulates Interleukin 12 Production by Macrophages in Murine Thy-1 Type Autoimmune Disease J. Biol. Chem., May 27, 2005; 280(21): 20879 - 20886. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Warren, A. J. Aldave, M. Srinivasan, E. J. Thonar, A. B. Kumar, V. Cevallos, J. P. Whitcher, and T. P. Margolis Novel Mutations in the CHST6 Gene Associated With Macular Corneal Dystrophy in Southern India Arch Ophthalmol, November 1, 2003; 121(11): 1608 - 1612. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Iida-Hasegawa, A. Furuhata, H. Hayatsu, A. Murakami, K. Fujiki, K. Nakayasu, and A. Kanai Mutations in the CHST6 Gene in Patients with Macular Corneal Dystrophy: Immunohistochemical Evidence of Heterogeneity Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3272 - 3277. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Plaas, L. A. West, E. J. A. Thonar, Z. A. Karcioglu, C. J. Smith, G. K. Klintworth, and V. C. Hascall Altered Fine Structures of Corneal and Skeletal Keratan Sulfate and Chondroitin/Dermatan Sulfate in Macular Corneal Dystrophy J. Biol. Chem., October 19, 2001; 276(43): 39788 - 39796. [Abstract] [Full Text] [PDF] |
||||


